Citations

Clear

3942 citation(s) found for "To, Van".

‘July effect’ in management and outcomes of patients admitted with pulmonary embolism in the United States, 2016 to 2021
Bansal, Mridul , Mehta, Aryan , Morris, D. Lynn, Mehta, Chirag, Abbott, J. Dawn, Vallabhajosyula, Saraschandra , Vallabhajosyula, Saraschandra , Jentzer, Jacob C. , Diepen, Sean van

Mayo Clinic

Baylor University Medical Center Proceedings | July 8, 2025 | Volume: 38 | Issue: 5 | Pages: 675-682

10.1080/08998280.2025.2520125 | PMID 40821483 Get It

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer
Cornet, Charlotte Le , Truong, Thérèse, Bolla, Manjeet K. , Koutros, Stella, Stone, Jennifer , Shulman, Katerina, Aronson, Kristan J. , Guénel, Pascal, Patel, Alpa V , Bodelón, Clara , Teras, Lauren R., Shahi, Shamim , Dossus, Laure, Kaaks, R., Holleczek, Bernd , Hoppe, Reiner , Czene, Kamila, Hall, P.F., Mannermaa, Arto, Wu, Anna H. , Obi, Nadia , Panayiotidis, Mihalis I. , Haiman, Christopher A., Shu, Xiao , Perou, Charles M. , Alsten, Sarah Van, Eliassen, A. Heather, Kraft, Peter, Ahearn, Thomas U., Evans, D. Gareth , Wolk, Alicja, Easton, Douglas F., Pharoah, Paul D. P., Vachon, Celine M. , Chang-Claude, Jenny, Evans, D Gareth , Perou, Charles M , Stone, Jennifer , Panayiotidis, Mihalis I , Jung, Audrey , Behrens, Sabine , Middha, Pooja , Truong, Thérèse , Jernström, Helena , Wang, Qin , Southey, Melissa C. , Freeman, Laura E. Beane , Koutros, Stella , Rennert, Gad , Murphy, Rachel A. , Guénel, Pascal , Teras, Lauren R. , Lacey, James V. , Dossus, Laure , Kaaks, Rudolf , Brenner, Hermann , Brauch, Hiltrud , Czene, Kamila, Mannermaa, Arto , Michailidou, Kyriaki , McLean, Catriona , Haiman, Christopher A., Augustinsson, Annelie , Zheng, Wei , Troester, Melissa A. , Abubakar, Mustapha , Ahearn, Thomas U., Wolk, Alicja , Milne, Roger L. , Easton, Douglas F. , Schmidt, Marjanka K. , García‐Closas, Montserrat , Vachon, Celine M. , Fortner, Renée T. , Chang‐Claude, Jenny

Mayo Clinic

JAMA Network Open | July 7, 2025 | Volume: 8 | Issue: 7 | Pages: e2519236

10.1001/jamanetworkopen.2025.19236 | PMID 40622713 Get It

ImportanceEtiologic heterogeneity in breast carcinogenesis needs to be well characterized for targeted prevention. Associations between menopausal hormonal therapy (MHT) and oral contraceptive (OC) use and breast cancer intrinsic-like subtypes are not well understood.ObjectiveTo examine whether exogenous hormone use is differentially associated with breast cancer subtypes and to evaluate heterogeneity by intrinsic-like subtypes.Design, Setting, and ParticipantsThis study pooled data from 31 nested and population-based case-control studies involved in the Breast Cancer Association Consortium. The study population included individuals with breast cancer and control participants from 13 case-control studies nested in prospective cohorts (recruited between 1982 and 2011) and 18 population-based case-control studies (recruited between 1990 and 2013). Data analysis was performed in June 2024.ExposureMHT use (estrogen-progestin therapy [EPT] or estrogen-only therapy [ET]) in postmenopausal women and OC use in premenopausal women (never, past use, or current use).Main Outcomes and MeasuresBreast cancer intrinsic-like subtypes (luminal A–like, luminal B–like, luminal B–ERBB2 [formerly HER2 or HER2/neu]-like, ERBB2 enriched–like, or triple-negative) were determined by immunohistochemistry of tumor sections. Polytomous logistic regression was performed to estimate the association between exogenous hormones and risk of breast cancer by intrinsic-like subtypes. Analyses by subtypes were stratified by body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]; healthy weight, 18.5-<25; overweight, 25-<30; or obesity, ≥30).ResultsThis study included 42 269 individuals with breast cancer (11 901 [28.2%] premenopausal and 30 368 [71.8%] postmenopausal; 23 353 [55.2%] had a known intrinsic-like subtype) and 71 072 control participants. The mean (SD) age of all participants was 57.9 (10.9) years. In postmenopausal women, associations between current MHT use (EPT or ET) and breast cancer differed by subtype. Current EPT users with healthy weight were more likely to be diagnosed with luminal A–like (odds ratio [OR], 2.51 [95% CI, 2.26-2.80]) or luminal B–ERBB2-like (OR, 1.95 [95% CI, 1.61-2.37]) subtypes. These associations were attenuated but remained for individuals with overweight (OR, 1.40 [95% CI, 1.02-1.92]) or obesity (OR, 1.68 [95% CI, 1.01-2.78]). EPT use increased the odds of being diagnosed with luminal B–like tumors solely in women with healthy weight (OR, 1.47 [95% CI, 1.17-1.86]). Current ET use was positively associated with luminal A–like disease in women with healthy weight only (OR, 1.16 [95% CI, 1.01-1.32]), showing inverse associations with higher BMI (obesity: OR, 0.65 [95% CI, 0.50-0.85]). In premenopausal women, recent OC use was associated with luminal B–ERBB2-like (OR, 1.50 [95% CI, 1.09-2.08]), ERBB2 enriched–like (OR, 2.33 [95% CI, 1.55-3.51]), and triple-negative (OR, 1.75 [95% CI, 1.33-2.29]; P < .04 for heterogeneity) tumors.Conclusions and RelevanceIn this study, clear differences were observed in associations between current EPT use and luminal-like breast cancer subtypes and other subtypes. EPT users with healthy weight were more likely to be diagnosed with luminal-like breast cancer compared with nonusers. Subtype heterogeneity was less apparent in associations of OC and ET use. Future studies on contemporary formulations, patterns of use, and routes of administration of exogenous hormone usage are warranted.
Left Atrial Diverticula Detected on Cardiac CT in Patients With Acute Ischemic Stroke: A Substudy of Mind the Heart
Nio, Shan Sui , Rinkel, Leon A. , Cramer, Olivia N. , Özata, Z. Beyda , Beemsterboer, Chiel F.P. , Guglielmi, Valeria , Bouma, Berto J. , Boekholdt, S. Matthijs , Lobé, N. H. J. , Beenen, Ludo F.M. , Roos, Yvo B.W.E.M. , Randen, Adriënne van , Lobé, Nick H J , Arrarte Terreros, Nerea , Marquering, Henk A , Majoie, Charles B L M , Roos, Yvo B W E M , van Randen, Adrienne , Planken, R Nils , Coutinho, Jonathan M , Beemsterboer, Chiel F P , Bouma, Berto J , Boekholdt, S Matthijs , Marquering, Henk A. , Majoie, Charles B.L.M. , Planken, R. Nils

Mayo Clinic

Stroke | July 7, 2025 | Volume: 56 | Issue: 9 | Pages: 2561-2570

10.1161/strokeaha.125.051199 | PMID 40620236 Get It

BACKGROUND: Left atrial (LA) diverticula are focal outpouchings of the LA wall and may increase ischemic stroke risk. We studied recurrent ischemic stroke in patients with acute ischemic stroke and LA diverticula detected on cardiac computed tomography. METHODS: We used data from a prospective cohort study of patients with acute ischemic stroke undergoing cardiac computed tomography acquired during the acute stroke imaging protocol. Cardiac radiologists systematically assessed the presence and characteristics of LA diverticula, defined as LA wall outpouchings with a length/ostium width ratio >0.5 and length ≥3 mm. We compared recurrent ischemic stroke and functional outcome (modified Rankin Scale) after 2 years between patients with and without LA diverticula, adjusting for age, history of atrial fibrillation and ischemic stroke, and anticoagulation use. RESULTS: Of 447 included patients (median age 72 [interquartile range (IQR), 62–81], 59% male), 126 (28%) had LA diverticula: median length 6 mm (IQR, 4–8), width 5 mm (IQR, 4–7), and volume 113 mm 3 (IQR, 52–254). There was no statistically significant difference in age (median 70 [IQR, 58–79] versus 73 [IQR, 63–81]; P =0.06), sex (64% versus 57% male; P =0.28), history of ischemic stroke (21% versus 17%; P =0.48), atrial fibrillation (11% versus 19%; P =0.09), or baseline National Institutes of Health Stroke Scale score (median 5 [IQR, 2–14] versus 5 [IQR, 3–14]; P =0.54) between patients with and without LA diverticula, respectively. Recurrent ischemic stroke was more common in patients with LA diverticula (18/124 [15%] versus 24/314 [8%], adjusted hazard ratio, 2.01 [95% CI, 1.08–3.77]), and recurrence risk increased with diverticulum volume (adjusted hazard ratio, 1.02 [95% CI, 1.01–1.03] per 10 mm 3 ). Functional outcome was better in patients with diverticula (median modified Rankin Scale score of 2 [IQR, 1–3] versus 3 [IQR, 1–6], adjusted common odds ratio, 0.62, [95% CI, 0.42–0.92]). CONCLUSIONS: LA diverticula are a common finding on cardiac computed tomography in patients with acute ischemic stroke, and the risk of recurrent ischemic stroke was increased in these patients, particularly in those with larger diverticula. Atrial diverticula may be a risk factor for recurrent ischemic stroke. REGISTRATION: URL: https://www.onderzoekmetmensen.nl/nl/trial/50352 ; Unique identifier: NL6413901818.
Multimodality Craniofacial Phenotyping of Congenital Facial Weakness Disorders
Almpani, Konstantinia , Devine, Kate, Mishra, Rashmi , Bassim, Carol W. , Ryzin, Carol Van, Barry, Brenda J. , Engle, Elizabeth C. , Collins, Francis S. , Manoli, Irini , Lee, Janice S. , Engle, Elizabeth C , Wang Jabs, Ethylin, Lee, Janice S , Manoli, Irini , Devine, Katelin R., Liberton, Denise K. , Facio, Flavia M. , Webb, Bryn D. , Jabs, Ethylin W

Mayo Clinic

The Cleft Palate Craniofacial Journal | July 4, 2025 | Volume: 63 | Issue: 6 | Pages: 1455-1468

10.1177/10556656251344128 | PMID 40611650 Get It

Objective Congenital facial weakness (CFW) disorders are a heterogeneous group of rare conditions, that present at birth, with reduced facial movement, and mask-like facies. This study utilized a multimodality approach to examine the craniofacial and intraoral phenotypes among CFW disorders: Moebius syndrome (MBS), Hereditary Congenital Facial Palsy (HCFP), β-tubulin isotype 3 syndrome (CFEOM3A-TUBB3), Carey-Fineman-Ziter syndrome (CFZS), and a group of rarer disorders (Other). Design Prospective cohort study. Setting: Dental clinic. Participants: Sixty individuals (sex ratio 1:1, mean age 26.2 ± 17.5 years) with a diagnosis of CFW. Interventions: Deep clinical craniofacial and dental phenotyping, three-dimensional facial surface and cone-beam computed tomography scans, and cephalometric and geometric morphometric analyses. Results CFEOM3A-TUBB3, MBS, and CFZS groups had the highest prevalence of craniofacial anomalies; HCFP individuals were least affected. CFEOM3A-TUBB3 had a higher prevalence of short lower face (75%), poor oral hygiene (100%)/decay (75%), and Class II malocclusion (87.5%). Moebius syndrome was associated with lagophthalmos (90.9%), tongue fissures (72.4%), tight/small oral orifice (51.7%), and tongue fasciculations (50%). Carey-Fineman-Ziter syndrome had oblong facial shape (100%), downward lip commissures (100%), and abnormal hearing (60%). Moderate-severe decay/gingivitis correlated with restricted oral orifice, common among patients with facial animation/sling surgery. Morphologically, the CFW cohort had a relatively small craniofacial centroid size, anthropometric measurements, and distinct craniofacial shapes for each subtype. Conclusions Congenital facial weakness can result in abnormal craniofacial development in addition to the loss of facial movement. Multimodality phenotypic characterization of CFW disorders elucidated key clinical findings and distinct craniofacial shape segregation among the different groups.
Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Siegler, James E. , Badillo‐Goicoechea, Elena , Penckofer, Mary , Eklund, Kelsey , Yaghi, Shadi , Stretz, Christoph , Lineback, Christina , Stamm, Brian , Peter, Shani , D’Souza, Marissa , Conyers, Frank, Khasiyev, Farid , Kerrigan, Deborah , Lewis, Skylar, Ali, Hamid , Nour, Hassan Aboul , Sharma, Richa, Glover, Patrick , Thompson, Sean, Alshaer, Qasem , Thottempudi, Neeharika, Melkumova, Emiliya , Chionatos, Rafail , Daniel, Jean-Philippe Auguste, Frankel, Michael , Dumitrașcu, Oana , Parikh, Parth , Doolittle, Charles, Yahnke, Ian, Sathya, Anvitha , Kang, Jieun , Kirchhoffer, Kaitlyn, Bowman, Anna, Smith, M. J., Asabere, Aaron, Shahrivari, Mahan, Sheibani, Nazanin , Krishnaiah, Balaji , Gaudio, Elizabeth, Rothstein, Aaron , Alvi, Muhammad M. , Annam, Saketh , Amankwah, Curtis , Kam, Wayneho , Abburi, Nandini , Rojas-Soto, Diana , Molaie, Amir , Khezri, Nicole, Zubair, Adeel , Abbasi, Mehdi , Coevering, Russell J. Van , Nedelcu, Simona , Herpich, Franziska , Chahien, Dalia, Sehgal, Siddharth, Liebeskind, David S. , Linares, Guillermo , Zha, Alicia , Sarkar, Monica , Xi, Romi, Nelson, Ashley, Qdais, Ahmad Abu, Kasab, Sami Al , Singh, Eesha , Patel, Vivek , Mehndiratta, Prachi , DeMarco, Alexis, Cucchiara, Brett , Omran, Setareh Salehi , Dubinski, Michael , Ackerman, Jiyoun, Thon, Jesse , Brown, Samantha , Siegler, James E , Goicoechea, Elena Badillo , Lineback, Christina M , Conyers, F Garrett , Aboul-Nour, Hassan , Sharma, Richa , Nahab, Fadi B , Glover, Patrick , Alshaer, Qasem N , de Havenon, Adam H , Melkumova, Emiliya , Chionatos, Rafail A , Jillella, Dinesh V , Frankel, Michael R , Dumitrascu, Oana M , Sathya, Anvitha , Smith, Matthew M , Brorson, James R , Elangovan, Cheran , Krishnaiah, Balaji , Sloane, Kelly L , Rothstein, Aaron , Alvi, Muhammad M , Kam, Wayneho , Abburi, Nandini , Farooqui, Mudassir , Molaie, Amir , Zubair, Adeel , Abbasi, Mehdi , Van Coevering, Russell J , Nedelcu, Simona , Liebeskind, David S. , Linares, Guillermo , Zha, Alicia , Abu Qdais, Ahmad , Al Kasab, Sami , Aziz, Yasmin , Mehndiratta, Prachi , Sharrief, Anjail , Cucchiara, Brett L , Salehi Omran, Setareh , Nguyen, Thanh N , Thon, Jesse , Yaghi, Shadi , Stretz, Christoph , Penckofer, Mary , Khasiyev, Farid , Brown, Samantha J , Eklund, Kelsey , Stamm, Brian , Daniel, Jean-Philippe Auguste , D'Souza, Marissa , Sharma, Richa , Thottempudi, Neeharika , Havenon, Adam de , Culbertson, Collin J , Jillella, Dinesh , Daniel, Jean-Philippe Auguste, Ro, Jennifer , Brown, Samantha, Doolittle, Charles, Brorson, James R. , Asabere, Aaron, Elangovan, Cheran , Chen, Lucia , Aziz, Yasmin , Nguyen, Thanh N. , Ackerman, Jiyoun

Mayo Clinic

Neurology | July 3, 2025 | Volume: 105 | Issue: 3 | Pages: No page available

10.1212/wnl.0000000000213876 | PMID 40609061 Get It

International Delphi Consensus on Medial Meniscal Root Tears Shows High Agreement on Diagnosis, Treatment, and Rehabilitation but Lack of Agreement on Treatment of Asymptomatic Tears
Chahla, Jorge , Chahla, Jorge, García, José Rafael , Tollefson, Luke V. , Dzidzishvili, Lika , Gerhold, Cameron , Krych, Aaron J. , LaPrade, Robert F., Group, Meniscus Root International Expert, Bassett, Ashley J., Bernholt, David L., Bhatia, Sanjeev, Bøe, Berte, Brown, Charles H., Chung, Kyu Sung, Cohen, Moisés, Engebretsen, Lars, Familiari, Filippo, Faucett, Scott C., Feucht, Matthias J., Furumatsu, Takayuki, Geeslin, Andrew G., Getgood, Alan M.J., Hiranaka, Takaaki, Inderhaug, Eivind, Iñiguez, C. Magaly, Johnson, Darren L., Kim, Jin Goo, Kim, Sung‐Hwan, Kodama, Yuya, Kon, Elizaveta, Kopf, Sebastian, LaPrade, Christopher M., Larson, Christopher M., Lee, Dhong Won, Lind, Martin, Logan, Catherine A., López‐Torres, Irene I., Lording, Timothy, Maestu, Rodrigo, Moatshe, Gilbert, Monson, Jill K., Murray, Iain R., Musahl, Volker, Vyhmeister, Roberto Negrin, Okazaki, Yuki, Parker, David, Petersen, Wolf, Riboh, Jonathan C., Seil, Romain, Servien, Elvire, Sonnery‐Cottet, Bertrand, Spalding, Tim, Stevenson, Ciara, Stuart, Michael J., Tanaka, Miho J., Tapasvi, Sachin, Tuca, Maria, Wal, Wybren A. van der, Verma, Nikhil N., Bormann, Richard PB. von, Yanke, Adam B., Krych, Aaron J., Kopf, Sebastian , Krych, Aaron J , Chahla, Jorge A , Chahla, Jorge, Allende, Felicitas , LaPrade, Robert F., Group, Meniscus Root International Expert, Bassett, Ashley J., Bernholt, David L., Bhatia, Sanjeev, Bøe, Berte, Brown, Charles H., Chung, Kyu Sung, Cohen, Moisés, Engebretsen, Lars, Familiari, Filippo, Faucett, Scott C., Feucht, Matthias J., Furumatsu, Takayuki, Geeslin, Andrew G., Getgood, Alan M.J., Hiranaka, Takaaki, Inderhaug, Eivind, Iñiguez, C. Magaly, Johnson, Darren L., Kim, Jin Goo, Kim, Sung‐Hwan, Kodama, Yuya, Kon, Elizaveta , LaPrade, Christopher M., Larson, Christopher M., Lee, Dhong Won, Lind, Martin, Logan, Catherine A., López‐Torres, Irene I., Lording, Timothy, Maestu, Rodrigo, Moatshe, Gilbert, Monson, Jill K., Murray, Iain R., Musahl, Volker, Vyhmeister, Roberto Negrin, Okazaki, Yuki, Parker, David, Petersen, Wolf, Riboh, Jonathan C., Seil, Romain, Servien, Elvire, Sonnery‐Cottet, Bertrand, Spalding, Tim, Stevenson, Ciara, Stuart, Michael J., Tanaka, Miho J., Tapasvi, Sachin, Tuca, Maria, Wal, Wybren A. van der, Verma, Nikhil N., Bormann, Richard PB. von, Yanke, Adam B., Krych, Aaron J.

Mayo Clinic

Arthroscopy | July 3, 2025 | Volume: 41 | Issue: 11 | Pages: 4683-4698

10.1016/j.arthro.2025.06.028 | PMID 40614908 Get It

Purpose To develop an expert consensus statement on the diagnosis, management, and rehabilitation of medial meniscal root tears (MMRTs) using a modified Delphi technique. Methods A working group developed statements on MMRT diagnosis, nonoperative management, surgical indications, surgical management, alignment, and rehabilitation using modified Delphi techniques. Fifty‐six experts were surveyed over 3 rounds to reach consensus, with agreement measured on a 5‐point Likert scale. Statements were included, revised, or excluded on the basis of predefined thresholds (≥75% agreement, <20% disagreement). Experts suggested revisions or new statements in the first 2 rounds, and final consensus statements were included. Results All 56 experts completed 3 survey rounds. Experts agreed that root tears may occur with no known history of trauma, typically in older patients, and that it should be diagnosed with an magnetic resonance imaging. In symptomatic patients with MMRTs without advanced osteoarthritis should be repaired using an anatomic transtibial pull‐out technique (performing a pie‐crusting technique can be helpful for visualization). Nonoperative management is advised for patients with advanced osteoarthritis. High tibial osteotomy may be considered for significant varus malalignment during MMRT repair. The only statement without consensus was the management of asymptomatic MMRTs with mild medial compartment cartilage wear, indicating ongoing debate. Conclusions Overall, 98% of statements reached consensus. There is agreement that magnetic resonance imaging is the gold standard for diagnosis. Symptomatic MMRTs without advanced osteoarthritis should be repaired early using an anatomic transtibial pull‐out technique. End‐stage knee osteoarthritis warrants nonoperative management of MMRTs, and a structured postoperative protocol with limited weightbearing and range of motion is essential after repair. No agreement was reached on managing asymptomatic MMRTs in patients without significant medial compartment degeneration. Meniscal centralization sutures may help in cases of substantial extrusion, but their routine use is debated. Level of Evidence Level V, consensus of expert opinion.
BubR1 Insufficiency Drives Transcriptomic Alterations and Pathology Associated With Cardiac Aging and Heart Failure
Pun, Renju, Haas, Aliya L., Thapa, Aradhana , Takafuji, S., Suzuki, Rexton M., Kay, Gabrielle F., Li, Zheng , Waknitz, Michelle , Kim, Michael , Baker, Darren J. , Deursen, Jan M. van , Sorgen, Paul L. , Gundry, Rebekah L. , North, Brian J. , Kim, Michael H , Baker, Darren J , Haas, Aliya L., Thapa, Aradhana, Takafuji, Sylar R.

Mayo Clinic

Aging Cell | July 3, 2025 | Volume: 24 | Issue: 9 | Pages: No page available

10.1111/acel.70160 | PMID 40607964 Get It

ABSTRACT Aging is a prominent risk factor for heart disease, driving pathological cardiac changes such as hypertrophy, fibrosis, and cellular senescence. While BubR1 has been linked to systemic aging in mammalian models, its specific role in regulating cardiac aging remains unclear. Here, we investigated how BubR1 regulates heart aging and its potential contribution to the pathogenesis of cardiac disease, including heart failure. BubR1 insufficiency in mice resulted in marked cardiac hypertrophy, increased fibrosis, and elevated markers of cellular senescence. Transcriptomic profiling revealed widespread disruption in key pathways involved in cardiac function, including ion channel regulation, cytoskeletal organization, and contractile fiber dynamics. Comparative analysis with aged hearts demonstrated shared dysregulated gene networks, linking BubR1 deficiency to age‐related cardiac dysfunction. Additionally, BubR1 hypomorphic hearts mirrored transcriptomic changes observed in end‐stage heart failure patients, and BubR1 protein levels were found to decline with age in the heart and were also significantly reduced in rodent models of heart failure and in heart failure patients. BubR1 reduction in cardiomyocytes in vitro led to an increased expression of markers of heart failure, hypertrophy, and cytoskeletal remodeling, underscoring an essential and direct role of BubR1 in maintaining cardiomyocyte health. Overall, our data suggest that BubR1 deficiency is a feature of cardiac aging and disease in humans, and that sustaining BubR1 expression may offer a potential therapeutic strategy to mitigate age‐associated cardiac decline and improve heart health in the elderly.
The Minnesota Conference proposed guidelines for education and training in clinical neuropsychology
Stringer, Anthony Y. , Fuchs, Kathleen , Edgar, Veronica Bordes , Correia, Stephen , Penna, Suzanne , Whiteside, Douglas M. , Bodin, Douglas, Butt, Sakina M. , Dodzik, Peter , Fernandes, Mary A. , Freece, Krista, Fuller, Richard, Getz, Glen E., Harder, Lana , Irani, Farzin , Janzen, Laura , Kaseda, Erin T. , Kramer, Megan , Kubu, Cynthia S. , Lafosse, Jose M., Lee-DaRocha, Jennifer, MacDonald, Beatriz , Strutt, Adriana M. , McBride, W.E., Mucci, Grace , Nayar, Kritika , Paltzer, June Yu, Ray, Courtney , Ready, Rebecca E. , Schmitt, Taylor Rose , Rush, Beth , Stanford, Lisa D., Patten, Ryan Van , Verroulx, Kris, Wilson, Jaime, Wright, Ingram , Zartman, Andrea L., Fujii, Daryl , Heffelfinger, Amy , Rey‐Casserly, Celiane , Whiteside, Douglas , Block, Cady, Calamia, Matthew , M Dotson, Vonetta , Johnstone, Brick , Kaseda, Erin , Madore, Michelle , Medina, Luis Daniel , Sperling, Scott , Stiers, William , Stricker, Nikki H , Bilder, Robert , Heffelfinger, Amy , Schmitter-Edgecombe, Maureen , Bristow, Thomas, Reyes, Anny , Block, Cady K. , Calamia, Matthew , Didehbani, Nyaz , Fuller, Richard, Harder, Lana, McBride, Will, Medina, Luis D. , Singh, Shifali M. , Sperling, Scott A. , Stricker, Nikki H. , Thornton, Allen E. , Vandermorris, Susan , Parsons, Thomas D. , Puente, Antonio E. , Roper, Brad L.

Mayo Clinic

The Clinical Neuropsychologist | July 2, 2025 | Volume: 40 | Issue: 2 | Pages: 331-375

10.1080/13854046.2025.2520957 | PMID 40604361 Get It

A supervised machine learning approach for predicting the need for postsurgical intervention in acromegaly
Shinya, Yuki , Hong, Sukwoo , Palit, Sandhya R. , Erickson, Dana , Sáez-Alegre, Miguel , Meyer, Fredric B. , Atkinson, John L. D., Herndon, Justine S, Pinheiro Neto, Carlos, Shinya, Yuki , Ghaith, Abdul Karim , Herndon, Justine , Bancos, Irina , Morshed, Ramin A. , Pinheiro‐Neto, Carlos , Gompel, Jamie J. Van

Mayo Clinic

Neurosurgical Focus | July 1, 2025 | Volume: 59 | Issue: 1 | Pages: E10

10.3171/2025.4.focus2597 | PMID 40591978 Get It

OBJECTIVE Patients with growth hormone (GH)–secreting pituitary adenomas (PAs) experience various symptoms and comorbidities, which can ultimately lead to increased mortality. This study aimed to develop and validate a machine learning (ML) model for predicting long-term outcomes in patients with GH-secreting PAs following endonasal transsphenoidal surgery (ETS). METHODS The authors conducted a retrospective three-institution cohort study that included patients with GH-secreting PAs treated with ETS between 2013 and 2023. Clinical, radiological, and biochemical data were collected. The main outcome of interest was the intervention-free rate (IFR) after primary ETS. Supervised ML algorithms, including decision trees and random forests, were developed to predict the IFR. Model performance was evaluated using area under the receiver operating characteristic curve (AUROC) and Shapley Additive Explanations (SHAP) values. RESULTS The median follow-up for 100 patients with GH-secreting PAs (53% female) was 64 months (range 1–130 months). Additional intervention for persistent or recurrent acromegaly was required in 32% of patients. Following primary ETS alone, the 3-year IFR was 70% and the 5-year IFR was 67%. Multiple ML models were developed and evaluated using AUROCs. The decision tree analysis achieved an accuracy of 81% and emphasized the importance of both gross-total resection (GTR) and patient age in determining the long-term IFR. To better understand the factors that contributed to model performance, SHAP analysis was applied to the best-performing model. The SHAP dependence plots showed that key factors associated with a longer IFR included tumor size < 9 mm, GTR, patient age > 65 years, and Knosp grade 0. CONCLUSIONS This ML model offers a more nuanced and potentially more accurate approach to identify patients more likely to develop recurrent or persistent acromegaly following primary ETS and require additional treatment. Following external validation, this ML model could improve personalized treatment planning and follow-up strategies and enhance patient care and resource allocation in clinical practice.